Net Loss: BioXcel Therapeutics reported an operating loss of $10.2 million and a net loss of $12.7 million for the first quarter of 2026, compared to an operating loss of $10.1 million and net loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results